Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

65.40
-2.3400-3.45%
Pre-market: 66.380.9800+1.50%05:46 EDT
Volume:10.36M
Turnover:679.05M
Market Cap:290.31B
PE:19.23
High:66.63
Open:66.61
Low:64.95
Close:67.74
Loading ...

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires Live
·
06 Mar

Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%

GuruFocus.com
·
06 Mar

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
06 Mar

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Associated Press Finance
·
06 Mar

Novo Nordisk launches $499 Wegovy cash option and home delivery

Yahoo Finance
·
06 Mar

Novo Nordisk's Cheaper Wegovy Offering Is Bad News for Hims & Hers Stock -- Barrons.com

Dow Jones
·
05 Mar

Why Novo Nordisk (NVO) Is Rising Today

Insider Monkey
·
05 Mar

Novo Nordisk Launches NovoCare Pharmacy to Ship Wegovy Doses to Users' Homes

Dow Jones
·
05 Mar

Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health

Blockhead
·
05 Mar

Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

Zacks
·
05 Mar

Novo Nordisk to Sell Wegovy at Discount for Cash-Paying US Customers

Reuters
·
05 Mar

GM, Novo Nordisk, Marvell, CrowdStrike: Stocks to watch today

Quartz
·
05 Mar

Weight-loss-drug price war is on, as Wegovy prices cut for monthly subscribers

Dow Jones
·
05 Mar

Novo Nordisk offers Wegovy at lowered cost, Hims & Hers Health shares fall

Investing.com
·
05 Mar

Novo Nordisk Launches Delivery Option Offering Lower-Priced Wegovy

MT Newswires Live
·
05 Mar

Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients

PR Newswire
·
05 Mar

Down 39%. Is Novo Nordisk Stock a Buy on the Dip?

Motley Fool
·
05 Mar

The Zacks Analyst Blog Novo Nordisk, The Coca-Cola, Wells Fargo and Star Group

Zacks
·
05 Mar

Top Research Reports for Novo Nordisk, Coca-Cola & Wells Fargo

Zacks
·
05 Mar

GLP1 Tracker: Lilly continues to outgrow Novo- analyst

Investing.com
·
05 Mar